Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Tax Provisions (2017 - 2024)

Historic Tax Provisions for vTv Therapeutics (VTVT) over the last 6 years, with Q1 2024 value amounting to $100000.0.

  • vTv Therapeutics' Tax Provisions changed N/A to $100000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $100000.0, marking a year-over-year change of. This contributed to the annual value of $100000.0 for FY2024, which is N/A changed from last year.
  • Per vTv Therapeutics' latest filing, its Tax Provisions stood at $100000.0 for Q1 2024.
  • Over the past 5 years, vTv Therapeutics' Tax Provisions peaked at $200000.0 during Q1 2022, and registered a low of $15000.0 during Q1 2021.
  • For the 3-year period, vTv Therapeutics' Tax Provisions averaged around $103750.0, with its median value being $100000.0 (2021).
  • Over the last 5 years, vTv Therapeutics' Tax Provisions had its largest YoY gain of 123333.33% in 2022, and its largest YoY loss of 123333.33% in 2022.
  • vTv Therapeutics' Tax Provisions (Quarter) stood at $100000.0 in 2021, then surged by 100.0% to $200000.0 in 2022, then tumbled by 50.0% to $100000.0 in 2024.
  • Its last three reported values are $100000.0 in Q1 2024, $200000.0 for Q1 2022, and $100000.0 during Q3 2021.